We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+24.48%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$127M
AUM Growth
–
Cap. Flow
+$116M
Cap. Flow %
91.23%
Top 10 Hldgs %
66.8%
Holding
30
New
30
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
QTNT
Quotient Limited Ordinary Shares
QTNT
+$14.4M
2
SNY icon
Sanofi
SNY
+$12.6M
3
GSK icon
GSK
GSK
+$9.42M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$8.2M
5
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$5.65M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.89%
2 Consumer Discretionary 4.45%
3 Miscellaneous 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
$21.8M 17.15%
+30,321
New +$14.4M
SNY icon
2
Sanofi
SNY
$107B
$11.8M 9.3%
+259,500
New +$12.6M
GSK icon
3
GSK
GSK
$102B
$8.99M 7.06%
+168,297
New +$9.42M
COV
4
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$8.74M 6.87%
+85,500
New +$8.2M
DMK
5
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$7.21M 5.66%
+16,694
New +$5.3M
PETX
6
DELISTED
Aratana Therapeutics, Inc.
PETX
$5.8M 4.56%
+325,420
New +$4.05M
AFAM
7
DELISTED
Almost Family Inc
AFAM
$5.67M 4.45%
+195,807
New +$5.49M
CFN
8
DELISTED
CAREFUSION CORPORATION
CFN
$5.32M 4.18%
+89,600
New +$5.15M
CAH icon
9
Cardinal Health
CAH
$54.6B
$5.01M 3.94%
+62,100
New +$4.9M
AGRX
10
DELISTED
Agile Therapeutics
AGRX
$4.6M 3.62%
+375
New +$4.77M
BDSI
11
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.47M 3.51%
+372,043
New +$5.65M
JNJ icon
12
Johnson & Johnson
JNJ
$646B
$4.18M 3.29%
+40,000
New +$4.22M
PFNX
13
DELISTED
Pfenex Inc.
PFNX
$4.03M 3.16%
+560,765
New +$4.25M
OPCH icon
14
Option Care Health
OPCH
$3.58B
$3.88M 3.05%
+138,655
New +$3.44M
ADMA icon
15
ADMA Biologics
ADMA
$2.09B
$2.75M 2.16%
+245,930
New +$2.81M
OFIX icon
16
Orthofix Medical
OFIX
$395M
$2.35M 1.84%
+78,007
New +$2.29M
FWP
17
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$2.27M 1.78%
+15,559
New +$2.24M
CNMD icon
18
CONMED
CNMD
$1.5B
$2.25M 1.77%
+50,100
New +$2.1M
ESPR
19
DELISTED
Esperion Therapeutics
ESPR
$2.17M 1.7%
+53,600
New +$1.64M
NSPH
20
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$2.11M 1.66%
+269,311
New +$2.51M
SRNE
21
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.86M 1.46%
+184,720
New +$936K
SCYX icon
22
SCYNEXIS
SCYX
$53.6M
$1.72M 1.35%
+2,157
New +$1.52M
TGTX icon
23
TG Therapeutics
TGTX
$8.26B
$1.63M 1.28%
+102,700
New +$1.34M
MMSI icon
24
Merit Medical Systems
MMSI
$5.4B
$1.61M 1.27%
+93,072
New +$1.38M
CBAY
25
DELISTED
Cymabay Therapeutics
CBAY
$1.2M 0.94%
+121,900
New +$980K
1
2

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Sio Capital Management, which disclosed 30 positions worth $127M. Its ten largest holdings account for 67% of the portfolio.

Its largest position is Quotient Limited Ordinary Shares: 30,321 shares worth $21.8M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, followed by Consumer Discretionary and Miscellaneous.

  • Sio Capital Management's largest Q4 2014 buy was Quotient Limited Ordinary Shares: 30,321 shares worth $21.8M.
  • Sio Capital Management's ten largest holdings make up 67% of its $127M portfolio in Q4 2014.
  • Sio Capital Management disclosed 30 positions in Q4 2014, its first 13F filing on record.

Based on Sio Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.